Zurich43 is a strategic alliance made up of the Foundation for Research on Information Technologies in Society (IT'IS) and two commercial SME;s - Schmid and Partner Engineering AG (SPEAG) and ZMT Zurich MEdTech AG (ZMT). Zurich43 is headquartered in Zurich, Switzerland.

LivaNova is a global medical technology company built on decades of experience and a relentless commitment to improve the lives of patients around the world. As a worldwide leader in cardiovascular and neuromodulation solutions, we are dedicated to helping create meaningful products and therapies that transform lives each and every day. It’s health innovation that truly matters.

THESS is in collaboration with several Departments of the Aristotle University of Thessaloniki. In particular the Physics Department, the Chemistry Department and the Clinical Neurophysiology Laboratory of the Medical School have already worked together with THESS employees in scientific projects.

BrainsWay’s flagship technology — Deep Transcranial Magnetic Stimulation (Deep TMS) – is broadening and deepening the capabilities of TMS beyond what is currently thought possible. Well-positioned as a leader in this rapidly-expanding field, BrainsWay is changing the future of mental health.

Synergia Medical is pioneering optoelectronics for neural stimulation therapies by developing an innovative, powerful and versatile neural stimulation technological platform. By doing so, Synergia Medical will improve patients’ quality of life and pave the way to new personalized therapies. THESS has collaborated with Synergia Medical in two neural stimulation related projects.

New Phase captures expertise and knowledge within the field of magnetic fluid hyperthermia. New Phase also specializes in the production and characterization of magnetic nanomaterials suitable for delivery of magnetic hyperthermia.